COMMUNIQUÉS West-GlobeNewswire

En 2018, Novartis a enregistré une forte croissance de ses ventes, avec une expansion de sa marge core, développé des plates-formes leaders de traitements de pointe, et recentré l'entreprise
30/01/2019
Hausse du chiffre d'affaires net de 5% (tcc[1], +6% USD) en 2018, soutenue par l'excellente performance des moteurs de croissance : Pharmaceuticals: cette unité opérationnelle a progressé de 7% (tcc), impulsée par [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
30/01/2019
Regulated information Gosselies, Belgium, 30 January 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
30/01/2019
Information réglementée Gosselies, Belgique, le 30 janvier 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]
ASLAN Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate Restructuring
29/01/2019
SINGAPORE, Jan. 29, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, today announced [...]
Inspire Medical Systems, Inc. Announces FDA Approval of New Sensing Lead
29/01/2019
MINNEAPOLIS, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Stryker reports 2018 results and 2019 outlook
29/01/2019
Kalamazoo, Michigan, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2018 and 2019 outlook: Fourth Quarter Highlights • Reported net sales [...]
Heather Rowe Named Dynavax’s Vice President of Investor Relations and Corporate Communications
29/01/2019
BERKELEY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]
GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease
29/01/2019
—Company Plans to Submit NDA for Voxelotor Under FDA Accelerated Approval Pathway Later This Year— SOUTH SAN FRANCISCO, Calif. , Jan. 29, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) [...]
Nuvectra Provides Update on Virtis™ FDA PMA Submission
29/01/2019
PLANO, Texas, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a medical device company dedicated to neuromodulation, announced today that the U.S. Food and Drug Administration (FDA) has advised [...]
Align Technology Announces Record 2018 Financial Results
29/01/2019
2018 revenues up 33.5% to a record $2.0 billion 2018 Invisalign volume of 1.2 million cases up 31.9% and iTero scanner volume up 77.2% 2018 operating margin of 23.7% and diluted EPS of $4.92 2018 Invisalign volume in [...]
Lutronic Vision Initiates Preclinical Trial of R:GEN™ Laser for the Treatment of Dry AMD
29/01/2019
BILLERICA, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision, a wholly-owned subsidiary of Lutronic Corporation, announced today that it has initiated a preclinical trial to determine the optimal setting for its [...]
National Research Corporation to Broadcast its 2018 Fourth Quarter and Year-End Conference Call Live on the Internet
29/01/2019
Lincoln, Nebraska, Jan. 29, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 fourth quarter and year-end earnings conference [...]
MediPharm Labs is Rolling in Canada, Looking Beyond; Plus Exclusive Interview -- CFN Media
29/01/2019
SEATTLE, Jan. 29, 2019 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
CROSSJECT : OBTENTION DU STATUT D'ETABLISSEMENT PHARMACEUTIQUE
29/01/2019
Communiqué de Presse Obtention du statut d'établissement pharmaceutique Dijon, le 29 janvier 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un [...]
Eurobio Scientific reaches the €50m sales mark in 2018
29/01/2019
EUROBIO SCIENTIFIC REACHES THE €50M SALES MARK IN 2018 Eurobio Scientific consolidated sales reached €50.6M in 2018, an 18% growth, confirming its position as a key player in in vitro diagnostics Activity grew by more [...]
Eurobio Scientific franchit le cap des 50 M€ de chiffre d'affaires en 2018
29/01/2019
EUROBIO SCIENTIFIC FRANCHIT LE CAP DES 50 M€ DE CHIFFRE D’AFFAIRES EN 2018 Le chiffre d’affaires consolidé du Groupe Eurobio Scientific atteint 50,6 M€ en 2018, en hausse de +18%, confirmant son statut d’acteur majeur [...]
Diamond CBD Presents Its Popular CBD Products to Large Drug Store Chains
29/01/2019
Passage of the farm bill and other local governmental actions have more retailers considering ways to meet the consumers' CBD needs FT LAUDERDALE, Fla., Jan. 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE - Diamond CBD [...]
NeuroMetrix Reports New Clinical Studies Published on DPNCheck
29/01/2019
WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheck ® clinical studies. DPNCheck is a point-of-care test that provides accurate and cost- [...]
Dr Alice Gottlieb présentera les résultats sur l’hidrosadénite suppurée au Congrès annuel de l'American Academy of Dermatology
29/01/2019
AUSTIN, Texas, 29 janv. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui que le Dr Alice Gottlieb, M.D., Ph.D., fera une présentation intitulée « Bermekimab Shows Efficacy for Treating [...]

Pages